Literature DB >> 24050936

Evaluation of the biodistribution of 11C-methionine in children and young adults.

Sebastian M Harris1, James C Davis, Scott E Snyder, Elizabeth R Butch, Amy L Vavere, Mehmet Kocak, Barry L Shulkin.   

Abstract

UNLABELLED: The purpose of this study was to evaluate the biodistribution of (11)C-labeled methionine in non-tumor-involved organs in pediatric patients studied for malignant diseases.
METHODS: Ninety-three children and young adults with known or suspected malignancies underwent (11)C-methionine PET and CT scans. Imaging began 5-15 min after injection of 740 MBq (20 mCi) per 1.7 m(2) of body surface area. Images were acquired from the top of the head through the mid thighs. Standardized uptake values were determined using regions of interest drawn on the CT image and transferred to the corresponding transverse PET slice.
RESULTS: The highest concentrations of (11)C-methionine were found in the pancreas and liver. Less intense uptake was seen in other regions, such as the salivary glands, tonsils, and bone marrow. There was little uptake in the lungs, fat (including brown adipose tissue), and muscle. Uptake in bone marrow, parotid glands, and tonsils was slightly but statistically significantly higher in men than women. Testicular, bone marrow, and left ventricular uptake increased with age. There was little variability statistically between comparisons of uptake change and groupings of age, race, sex, and patients studied at the time of diagnosis versus previously treated patients.
CONCLUSION: High uptake of (11)C-methionine is reliably found in the pancreas and liver, consistent with the anabolic functions of these organs. Low uptake in the brain, neck, chest, pelvis, and extremities will facilitate tumor localization in those areas. However, intense uptake in the upper abdomen may limit the diagnostic utility of (11)C-methionine in that area.

Entities:  

Keywords:  11C; PET/CT; methionine; pediatric; tumor

Mesh:

Substances:

Year:  2013        PMID: 24050936      PMCID: PMC3924715          DOI: 10.2967/jnumed.112.118125

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  37 in total

1.  Role of positron emission tomography in lymphoma.

Authors:  Malik E Juweid; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

2.  Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.

Authors:  Hiroshi Uchino; Yoshikatsu Kanai; Do Kyung Kim; Michael F Wempe; Arthit Chairoungdua; Emiko Morimoto; M W Anders; Hitoshi Endou
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

3.  Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.

Authors:  T Yasukawa; K Yoshikawa; H Aoyagi; N Yamamoto; K Tamura; K Suzuki; H Tsujii; H Murata; Y Sasaki; T Fujisawa
Journal:  J Nucl Med       Date:  2000-02       Impact factor: 10.057

4.  Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

Authors:  June-Key Chung; Yu Kyeong Kim; Seok-ki Kim; Yong Jin Lee; Suntta Paek; Jeong Seok Yeo; Jae Min Jeong; Dong Soo Lee; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02       Impact factor: 9.236

5.  PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer.

Authors:  Hinrich Wieder; Katja Ott; Frank Zimmermann; Hjalmar Nekarda; Jens Stollfuss; Petra Watzlowik; Jörg-Rüdiger Siewert; Ulrich Fink; Karen Becker; Markus Schwaiger; Wolfgang Andreas Weber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-13       Impact factor: 9.236

6.  Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.

Authors:  David E Kang; Richard L White; James H Zuger; Howell C Sasser; Chris M Teigland
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

7.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

Authors:  Wolfgang A Weber; Volker Petersen; Burkhard Schmidt; Leishia Tyndale-Hines; Thomas Link; Christian Peschel; Markus Schwaiger
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.

Authors:  Lutz W Kracht; Michael Friese; Karl Herholz; Roland Schroeder; Bernd Bauer; Andreas Jacobs; Wolf-Dieter Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

9.  [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Takashi Tomemori; Kenji Sagou; Mei Tian; Susumu Kandatsu; Tadashi Kamada; Hiroshi Tsuji; Tetsuya Suhara; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

10.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Authors:  Sungeun Kim; June-Key Chung; So-Hyang Im; Jae Min Jeong; Dong Soo Lee; Dong Gyu Kim; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

View more
  13 in total

1.  Comparison of autologous (111)In-leukocytes, (18)F-FDG, (11)C-methionine, (11)C-PK11195 and (68)Ga-citrate for diagnostic nuclear imaging in a juvenile porcine haematogenous staphylococcus aureus osteomyelitis model.

Authors:  Ole L Nielsen; Pia Afzelius; Dirk Bender; Henrik C Schønheyder; Páll S Leifsson; Karin M Nielsen; Jytte O Larsen; Svend B Jensen; Aage Ko Alstrup
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

2.  Utility of 11C-methionine and 11C-donepezil for imaging of Staphylococcus aureus induced osteomyelitis in a juvenile porcine model: comparison to autologous 111In-labelled leukocytes, 99m Tc-DPD, and 18F-FDG.

Authors:  Pia Afzelius; Aage Ko Alstrup; Henrik C Schønheyder; Per Borghammer; Svend B Jensen; Dirk Bender; Ole L Nielsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

Review 3.  Non-FDG PET/CT in Diagnostic Oncology: a pictorial review.

Authors:  Francesco Giammarile; Paolo Castellucci; Rudi Dierckx; Enrique Estrada Lobato; Mohsen Farsad; Roland Hustinx; Amirreza Jalilian; Olivier Pellet; Susana Rossi; Diana Paez
Journal:  Eur J Hybrid Imaging       Date:  2019-11-29

Review 4.  From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application.

Authors:  Aleksandra Pekošak; Ulrike Filp; Alex J Poot; Albert D Windhorst
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

5.  Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti; Shuntaro Oka; Hiroyuki Okudaira; Yusuke Inoue; Jens Sörensen; Rikard Owenius; Peter Choyke; Baris Turkbey; Trond V Bogsrud; Tore Bach-Gansmo; Raghuveer K Halkar; Jonathon A Nye; Oluwaseun A Odewole; Bital Savir-Baruch; Mark M Goodman
Journal:  J Nucl Med       Date:  2014-11-13       Impact factor: 10.057

6.  Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.

Authors:  Katharina Lückerath; Constantin Lapa; Annika Spahmann; Gerhard Jörg; Samuel Samnick; Andreas Rosenwald; Herrmann Einsele; Stefan Knop; Andreas K Buck
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

7.  Amino acid transport system - A substrate predicts the therapeutic effects of particle radiotherapy.

Authors:  Tomoya Uehara; Mariko Watanabe; Hiroyuki Suzuki; Yoshiya Furusawa; Yasushi Arano
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

8.  Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  Pilar Jimenez-Royo; Michele Bombardieri; Coziana Ciurtin; Michalis Kostapanos; Anwar R Tappuni; Natasha Jordan; Azeem Saleem; Teresa Fuller; Kathleen Port; Elena Pontarini; Davide Lucchesi; Robert Janiczek; Paul Galette; Graham Searle; Neel Patel; Lucy Kershaw; Calum Gray; Nirav Ratia; André van Maurik; Marius de Groot; Nicolas Wisniacki; Mats Bergstrom; Ruth Tarzi
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

9.  Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.

Authors:  James T Thackeray; Jens P Bankstahl; Yong Wang; Kai C Wollert; Frank M Bengel
Journal:  Theranostics       Date:  2016-07-15       Impact factor: 11.556

10.  Assessment of Amino Acid/Drug Transporters for Renal Transport of [18F]Fluciclovine (anti-[18F]FACBC) in Vitro.

Authors:  Masahiro Ono; Atsumi Baden; Hiroyuki Okudaira; Masato Kobayashi; Keiichi Kawai; Shuntaro Oka; Hirokatsu Yoshimura
Journal:  Int J Mol Sci       Date:  2016-10-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.